These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 34295329)

  • 1. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.
    Franzin R; Stasi A; Fiorentino M; Simone S; Oberbauer R; Castellano G; Gesualdo L
    Front Immunol; 2021; 12():673562. PubMed ID: 34295329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.
    Resch T; Cardini B; Oberhuber R; Weissenbacher A; Dumfarth J; Krapf C; Boesmueller C; Oefner D; Grimm M; Schneeberger S
    Front Immunol; 2020; 11():631. PubMed ID: 32477321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies to optimize kidney recovery and preservation in transplantation.
    Bon D; Chatauret N; Giraud S; Thuillier R; Favreau F; Hauet T
    Nat Rev Nephrol; 2012 May; 8(6):339-47. PubMed ID: 22549229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation.
    Schlegel A; Muller X; Kalisvaart M; Muellhaupt B; Perera MTPR; Isaac JR; Clavien PA; Muiesan P; Dutkowski P
    J Hepatol; 2019 Jan; 70(1):50-57. PubMed ID: 30342115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine perfusion of donor organs for transplantation.
    Tatum R; O'Malley TJ; Bodzin AS; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):682-695. PubMed ID: 33349946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H
    Juriasingani S; Akbari M; Chan JY; Whiteman M; Sener A
    Nitric Oxide; 2018 Dec; 81():57-66. PubMed ID: 30393129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation.
    Kaths JM; Spetzler VN; Goldaracena N; Echeverri J; Louis KS; Foltys DB; Strempel M; Yip P; John R; Mucsi I; Ghanekar A; Bagli D; Robinson L; Selzner M
    J Vis Exp; 2015 Jul; (101):e52909. PubMed ID: 26275014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of machine perfusion preservation of liver grafts from donation after cardiac death.
    Matsuno N; Uchida K; Furukawa H
    Transplant Proc; 2014 May; 46(4):1099-103. PubMed ID: 24815138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of transplant kidneys during machine perfusion.
    Hosgood SA; Hoff M; Nicholson ML
    Transpl Int; 2021 Feb; 34(2):224-232. PubMed ID: 32970886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of hypothermic ex vivo perfusion on ischemia/reperfusion injury and transplant outcomes.
    Henry SD; Guarrera JV
    Transplant Rev (Orlando); 2012 Apr; 26(2):163-75. PubMed ID: 22074785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex-vivo machine perfusion for kidney preservation.
    Hamar M; Selzner M
    Curr Opin Organ Transplant; 2018 Jun; 23(3):369-374. PubMed ID: 29697462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cells as Anti-Inflammatory and Regenerative Mediators for Donor Kidneys During Normothermic Machine Perfusion.
    Sierra-Parraga JM; Eijken M; Hunter J; Moers C; Leuvenink H; Møller B; Ploeg RJ; Baan CC; Jespersen B; Hoogduijn MJ
    Stem Cells Dev; 2017 Aug; 26(16):1162-1170. PubMed ID: 28557562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ischemia-reperfusion. Preservation solution and hypothermic machine perfusion].
    Barrou B; Chatauret N; Hauet T; Thuret R; Kleinclauss F; Timsit MO; Codas R; Matillon X; Badet L
    Prog Urol; 2016 Nov; 26(15):964-976. PubMed ID: 27693279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro/Ex Vivo Models for the Study of Ischemia Reperfusion Injury during Kidney Perfusion.
    Giraud S; Thuillier R; Cau J; Hauet T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does machine perfusion decrease ischemia reperfusion injury?
    Bon D; Delpech PO; Chatauret N; Hauet T; Badet L; Barrou B
    Prog Urol; 2014 Jun; 24 Suppl 1():S44-50. PubMed ID: 24950933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation.
    Li J; Peng Q; Yang R; Li K; Zhu P; Zhu Y; Zhou P; Szabó G; Zheng S
    Front Immunol; 2021; 12():713920. PubMed ID: 35024039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of normothermic machine perfusion in liver transplantation.
    Martins PN; Buchwald JE; Mergental H; Vargas L; Quintini C
    Int J Surg; 2020 Oct; 82S():52-60. PubMed ID: 32417462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Current Machine Perfusion Therapeutics for Organ Preservation.
    Xu J; Buchwald JE; Martins PN
    Transplantation; 2020 Sep; 104(9):1792-1803. PubMed ID: 32371846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermic Machine Perfusion Results in a Marginal Kidney Transplant Programme.
    Gómez-Dos Santos V; Ruiz Hernández M; Burgos-Revilla FJ
    Eur Urol Focus; 2018 Mar; 4(2):163-168. PubMed ID: 29929872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normothermic machine perfusion of the kidney: better conditioning and repair?
    Hosgood SA; van Heurn E; Nicholson ML
    Transpl Int; 2015 Jun; 28(6):657-64. PubMed ID: 24629095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.